Home
About Us
Discovery Services
Research Services & Partnering
Research Software
Resource Library
Investors
Contact Us

Transforming Drug Discovery

MENU

Resource Library

Blogs
- Ask the Expert Blog
- Scientific Blog
Case Studies
Flow Cytometry Panels
Infographics
Model Spotlights
PDX Model Cohorts
Posters
Publications
Research Platforms
Software Platforms
Videos
Webinars
White Papers

Posters

Always at the forefront of the dynamic patient-derived xenograft (PDX) market, Champions Oncology has emerged as a respected key opinion leader on the utilization and benefits of PDX models in oncology drug development.

2022

SABCS 2022 Poster San Antonio Breast Cancer Symposium 2022: Combining Multiomics and Histological Assessment to Identify Patient Derived Xenograft Models of Invasive Lobular Carcinoma

2022 AACR - AML AACR 2022: A Pharmaco-Pheno-Multiomic Integration Analysis of Primary Acute Myeloid Leukemia Reveals Biomarkers of Cytarabine Resistance

2022 AACR - Ovarian AACR 2022: Pharmaco-Pheno-Multiomic Integration Builds A Biomarker Network of Olaparib Resistance in Ovarian Cancer

2021

2021 AACR - CLL AACR 2021: In Vitro Drug Sensitivity Screening Platform for Chronic Lymphocytic Leukemia (CLL) Patient Samples

2021 AACR - BALL AACR 2021: In Vitro and In Vivo Model for Evaluation of Novel Therapeutic Agents in Patient-Derived Lymphoblastic Leukemia (B-ALL)

2021 AACR TIL AACR 2021: Unique 3D Organoids Autologous TIL Co-Culture Platform Enables High Throughput Immune-Oncology Drug Response Studies

2021_ASH_Novel ALL ASH 2021: Novel In Vitro and In Vivo Drug Screening Platform for ALL

ASH 2021 SITC 2021: 3D Co-Culture Platform Reveals Insights into Patient Autologous Immune Cell-Tumor Interaction and Immune Modulation In Vitro

2020

2020 AACR - AML AACR 2020: 2D Ex Vivo Patient-Derived Acute Myeloid Leukemia Platform for Evaluation of Novel Molecular Targeted Therapeutic Agents

2020 AACR - NK AACR 2020: Natural Killer (NK) Human Immune System (HIS) ImmunoGraft^® Platform to Evaluate the Pharmacodynamics of Immuno-Oncology Therapeutics

2020_SITC_AutoTIL SITC 2020: Development of a 3D Organoid Autologous TIL Co-Culture Platform for High Throughput Immuno-Oncology Studies

2019

AACR 2019 - AML AACR 2019: Establishment of a Patient-Derived Acute Myeloid Leukemia (AML) Ex Vivo Platform for Evaluation of Novel Therapeutic Agents

2019_NYAS_PT NYAS 2019: Unique Immunodeficient Murine Host Strains Impact Expansion and Engraftment of T Cells in PBMC Humanized Mice

2019_SITC_NK SITC 2019: Development of a Natural Killer (NK) ImmunoGraft ^® Platform for the Evaluation of Pharmacodynamics of Immuno Oncology Therapeutics

2019_SITC_PBMC SITC 2019: Development of a Peripheral Blood Mononuclear Cells (PBMC) ImmunoGraft^® Platform to Evaluate of the Pharmacodynamics of Immuno Oncology Therapeutics

2018

2018_AACR_PALB AACR 2018: Inflammatory and Stem-Like Colorectal Cancer (CRC) Subtypes Identified in Patient-Derived Xenograft (PDX) Models Show Tumor Growth Inhibition (TGI) by the Combination of Trametinib (T) and Neratinib (N) Irrespective of KRAS Mutation (MT) Status

2018_EORTC_NOG EORTC 2018: Establishment of ImmunoGraft ^® with Human Immune System (HIS) and PDX Co-Engraftment Using NOG-EXL Mice to Evaluate Checkpoint Inhibitors

2018_EORTC_Prostate EORTC 2018: Patient-Derived Xenograft (PDX) Models from Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Reflect Clinical Disease and Therapeutic Outcomes

2018_SITC_Autologous SITC 2018: Autologous Human Immune System (HIS) ImmunoGraft ^®: Mobilized Peripheral Blood (MPB) Derived CD34 Engraftment and Lineage Development

2018_SITC_Haplotype SITC 2018: Haplotype Human Immune System (HIS) Modeling and Co-Engraftment of PDX: ImmunoGraft Platform for Evaluation of Pharmacodynamics of Immuno Oncology Therapeutics

2017

2017_AACR_Her2 AACR 2017: Patient-Derived Xenograft (PDX) Models Expressing HER2 Reflect Clinical Responses to Targeted HER2 Inhibition

2017_EORTC_NSCLC EORTC 2017: Patient-Derived Xenograft (PDX) Models of NSCLC Reflect Clinical Drug Responses and Predict Effective Treatments for Patients

Home
About Us
Therapeutic Discovery
Research Software

Research Partnering
Resource Library
Upcoming Events
Investors

News
Careers
Contact Us

Lumin Bioinformatics
Model Select^®
Cell Line Select^®

Copyright © 2023
Champions Oncology, Inc. All Rights Reserved